PNC Financial Services Group’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-5,000
Closed -$15K 4696
2021
Q3
$15K Buy
+5,000
New +$17.8K ﹤0.01% 3633
2021
Q2
Sell
-1,500
Closed -$8K 4332
2021
Q1
$8K Buy
+1,500
New +$7.78K ﹤0.01% 3719

Other funds holding AGTC

PNC Financial Services Group's AGTC Position: Q4 2021 in Review

PNC Financial Services Group sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2021, closing a stake of 5,000 shares — an estimated $15K sold.

PNC Financial Services Group first reported a position in AGTC in Q1 2021 and held it in 2 quarters. The position peaked at $15K in Q3 2021. 55 funds tracked by Wall St. Rank hold AGTC as of Q4 2021.

  • PNC Financial Services Group reported no remaining Applied Genetic Technologies Corporation position as of Q4 2021 after selling out during the quarter.
  • PNC Financial Services Group sold 5,000 Applied Genetic Technologies Corporation shares in Q4 2021, an estimated $15K.
  • PNC Financial Services Group first reported a position in Applied Genetic Technologies Corporation in Q1 2021 and held it in 2 quarters.
  • PNC Financial Services Group's Applied Genetic Technologies Corporation position peaked at $15K in Q3 2021.
  • 55 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2021.

Based on PNC Financial Services Group's 13F filing for Q4 2021, filed 11 Feb 2022.